Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 34 Issue 7, July 2016

A scanning electron micrograph of bone tissue. The bone marrow (orange) provides the niche for hematopoietic stem cells. Palchaudhuri et al. describe an antibody-based agent for depleting cells in the bone marrow before hematopoietic stem cell transplantation (p 738). Image credit: Steve Gschmeissner, Science Source

Editorial

  • Headlines about a proposal to engineer an entirely synthetic human genome largely missed the point.

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

Bioentrepreneur

  • Academic institutions need to prioritize how they incorporate terms for royalty streams into license agreements.

    • Michael A Reslinski
    • Bernhard S Wu
    Bioentrepreneur
Top of page ⤴

Correspondence

Top of page ⤴

Feature

  • Last year witnessed the biotech sector's first retreat from a multi-year run of incredible performance on the public markets.

    • Chris Morrison
    • Riku Lähteenmäki
    Feature
Top of page ⤴

Patents

Top of page ⤴

News & Views

Top of page ⤴

Analysis

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Careers and Recruitment

Top of page ⤴

Search

Quick links